As Some VCs Refill, Others Are Running Out Of Gas

Life science VCs are posting strong across-the-board returns, allowing some firms to raise new funds larger than their prior vehicles. Still, the contraction that began nearly five years ago continues to thwart other firms’ efforts to press on through hard times.